Skip to main
NRSN

NRSN Market Capitalization Overview

Market Cap: $12.75M as of Sep 17, 2026

$12.75M
$247.84M (95.11%)past month
As of Sep 17, 2026, NRSN has a market capitalization of $12.75M. Over the past 30 days, its market cap has increased by , while in the last 12 months, it has increased by .

Market capitalization represents the total value of NeuroSense Therapeutics Ltd as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

NRSN Market Cap Formula = Stock Price * Shares Outstanding

The market cap of NRSN helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NRSN Market Cap History

DateMarket CapChange
Sep 14, 2026$260.59M

NRSN End of Year Market Cap History

DateMarket CapChange
2026$12.75M

FAQs About NeuroSense Therapeutics Ltd (NRSN) Market Cap

As of Sep 17, 2026, the market capitalization of NRSN is $12.75M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, NeuroSense Therapeutics Ltd’s market capitalization has decreased by -95.11%, changing from $260.59M to $12.75M as of Sep 17, 2026.

In the last 3 months, NeuroSense Therapeutics Ltd’s market capitalization has increased by —, changing from – to – as of –.

In the year –, NeuroSense Therapeutics Ltd’s market capitalization increased from – in January to – in December, reflecting a — change.

NeuroSense Therapeutics Ltd (NRSN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.